An objective evaluation of muscle oxygen content in claudicants receiving drug therapy

International Angiology

Volumn 15, Issue 3, 1996, Pages 215-218

  Komiyama, Takashi ^a   Shigematsu, Hiroshi ^a   Yasuhara, Hiroshi ^a   Hosoi, Yutaka ^a   Muto, Tetsuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arteriosclerosis obliterans; Drug therapy; Intermittent claudication; PGI2 analog (beraprost sodium); Spectroscopy, near infrared

Indexed keywords

BERAPROST; DEOXYHEMOGLOBIN; OXYHEMOGLOBIN; PROSTAGLANDIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; GASTROCNEMIUS MUSCLE; HUMAN; INFRARED SPECTROSCOPY; INTERMITTENT CLAUDICATION; MALE; ORAL DRUG ADMINISTRATION; OXYGEN TISSUE LEVEL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TREADMILL; WALKING;

AGED; AGED, 80 AND OVER; EPOPROSTENOL; EXERCISE TEST; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; MUSCLES; OXYGEN; OXYHEMOGLOBINS; PLATELET AGGREGATION INHIBITORS; SPECTROPHOTOMETRY, INFRARED;

EID: 0029827374     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Berglund B, Eklund B. Reproducibility of treadmill exercise in patients with intermittent claudication. Clin Physiol 1981;1:253-6.
2. Jobsis FF. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977;198:1264-7.
3. Seiyama A, Hazeki O, Tamura M. Noninvasive quantitative analysis of blood oxygenation in rat skeletal muscle. J Biochem 1988;103:419-24.
4. Komiyama T, Shigematsu H, Yasuhara H et al. An objective assessment of intermittent claudication by near-infrared spectroscopy. Eur J Vasc Surg 1994;8: 294-6.
5. Cheatle TR, Potter LA, Cope M et al. Near-infrared spectroscopy in peripheral vascular disease. Br J Surg 1991;78:405-8.
6. McCully KK, Halber C, Posner JD. Exercise-induced changes in oxygen saturation in the calf muscles of elderly subjects with peripheral vascular disease. J Gerontol 1994;49(3):B128-B134.
7. Brazy JE, Lewis DV, Mitnick MH et al. Noninvasive monitoring of cerebral oxygenation in preterm infants: Preliminary observations. Pediatrics 1985;75:217-25.
8. Wyatt JS, Cope M, Delpy DT et al. Quantification of cerebral oxygenation and hemodynamics in sick newborn infants by near infrared spectrophotometry. Lancet 1986;2:1063-6.
9. Hands LJ, Bore PJ, Galloway G et al. Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy. Clin Sci 1986;71:283-90.
10. Zatina MA, Berkowitz HD, Gross GM et al. 31P nuclear magnetic resonance spectroscopy: Noninvasive biochemical analysis of the ischemic extremity. J Vasc Surg 1986;3:411-20.
11. Keller U, Oberhansli R, Huber P et al. Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs. Eur J Clin Invest 1985; 15:382-8.
12. Delpy DT, Cope M, van der Zee P et al. Estimation of optical pathlength through tissue from direct time flight measurement. Phys Med Biol 1988;33:1433-42.
13. De Blasi RA, Ferrari M, Natali A et al. Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy. J Appl Physiol 1994;76:1388-93.
14. Patterson MS, Chance B, Wilson BC. Time resolved reflectance and transmittance for the noninvasive measurement of tissue optical properties. J Appl Optics 1989;28:2331-6.
15. Cui W, Kumar C, Chance B. Experimental study of migration depth for the photons measured at sample surface. SPIE Vol. 1431. Time-resolved Spectroscopy and Imaging of Tissue, 1991:180-91.
16. Coffman JD. Vasodilator drugs in peripheral vascular disease. N Engl J Med 1979;300:713-7.
17. Porter JM, Baur GM. Pharmacologic treatment of intermittent claudication. Surgery 1982;92(6):966-71.